Compare GSK plc (GSK) vs Upwork Inc (UPWK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GSK plc vs Upwork Inc — how do they compare? GSK plc trades at $52.64 (market cap $101.34B), while Upwork Inc trades at $9.36 (market cap $1.14B). The key difference: GSK plc is far larger — about 88.9× Upwork Inc's market cap, and GSK plc pays a 3.49% dividend while Upwork Inc pays none. Which is the better fit depends on your goals.
| GSK | UPWK | |
|---|---|---|
Market Cap | $101.34B | $1.14B |
Sector | Health | Industrials |
52-Week High | $61.18 | $22.11 |
52-Week Low | $36.20 | $7.84 |
Enterprise Value | $121.95B | $939.82M |
Dividend Yield | 3.49% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GSK's stock trades at $51.25, down 1.99% on the day, with a bearish technical signal from moving averages. Fundamentally, the company shows strong profitability with a 17.78% net margin and 36.42% ROE, supported by a consistent earnings beat history. Recent positive clinical trial results for Jemperli in rectal cancer and FDA approval for Utebzi highlight pipeline progress. Valuation appears reasonable with a P/E of 13.71 and EV/EBITDA of 9.16.
The outlook balances a solid core business and promising oncology pipeline against a mixed analyst consensus and near-term cash flow pressures. Key opportunities lie in execution of new drug launches and the upcoming CEO strategy update, while risks include clinical trial setbacks, competitive pressures, and integration of potential acquisitions like Nuvalent.
Upwork (UPWK) trades at $9.03, down 0.99% on the day, with a bullish technical signal from moving averages and neutral oscillators. The company reported $787.78M revenue for 2025 with strong profitability margins (77.54% gross margin, 13.81% net margin) but has missed EPS estimates for three consecutive quarters. Recent developments include AI integration partnerships and board refreshment, though multiple law firms are investigating potential securities law violations following a 19% stock decline after Q1 2026 results.
The stock presents a mixed outlook with attractive valuation metrics (P/E 11.4, P/S 1.62) and analyst consensus target of $10.67 (18% upside), but faces near-term headwinds from earnings misses and legal investigations. Key risks include execution challenges in AI integration and competitive pressure in the gig economy space, while opportunities lie in the company's capital-light marketplace model and growing freelance adoption.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →About Upwork Inc
Upwork Inc is a United States-based company that operates an online marketplace that enables businesses to find and work with highly-skilled independent professionals. The develops platform for hiring and freelancing purposes. Its products offering include Upwork Basic, Upwork Plus, Upwork Business, Upwork Enterprise, and Upwork Payroll. The business generates revenue from Talent and Clients across the USA, India, the Philippines and the rest of the world. Substantial income is derived from providing services to Clients.
Read more on UPWK →
